Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Stifel Maintains Hold on Badger Meter, Lowers Price Target to $79

Stifel Maintains Hold on Badger Meter, Lowers Price Target to $79

Stifel analyst Nathan Jones maintains Badger Meter (NYSE:BMI) with a Hold and lowers the price target from $88 to $79.

byBenzinga Newsdesk

July 20, 2022

1 minute read

Stifel analyst Nathan Jones maintains Badger Meter (NYSE:BMI) with a Hold and lowers the price target from $88 to $79.

Analyst Ratings

The Analyst Landscape: 5 Takes On Extreme Networks

By Benzinga Insights

April 15, 8:00 AM

Ratings for Extreme Networks (NASDAQ:EXTR) were provided by 5 analysts in the past three months, showcasing a mix…

EXTR

News

Why Longeveron (LGVN) Stock Exploded Higher Today

By Henry Khederian

April 8, 2:28 PM

Longeveron shares are trading higher Monday afternoon. The company announced it submitted paperwork for a share offering.

LGVN

Analyst Ratings

Breaking Down Olin: 7 Analysts Share Their Views

By Benzinga Insights

January 29, 11:00 AM

7 analysts have shared their evaluations of Olin (NYSE:OLN) during the recent three months, expressing a mix of…

OLN

Bio-Path Holdings Announces First Patient Dosed In Phase 1/1b Study Of BP1002 In Refractory/Relapsed Acute Myeloid Leukemia Patients

By Benzinga Newsdesk

October 24, 7:03 AM

Bio-Path Holdings, Inc., (NASDAQ:BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today

BPTH

Stifel Maintains Hold on Badger Meter, Lowers Price Target to $79

Related Posts

The Analyst Landscape: 5 Takes On Extreme Networks

Why Longeveron (LGVN) Stock Exploded Higher Today

Breaking Down Olin: 7 Analysts Share Their Views

Bio-Path Holdings Announces First Patient Dosed In Phase 1/1b Study Of BP1002 In Refractory/Relapsed Acute Myeloid Leukemia Patients